afrol News / SciDev.Net - June 7, 2007
Talent Ngandwe
The Zambian Pharmaceutical Regulatory Authority, under the Ministry of Health, has summoned a businessman from the city of Lusaka and his American associate to appear before a committee of experts to answer questions on the chemical Tetrasil. The Zambian government requires anyone claiming to have a drug to cure HIV/AIDS to submit samples to the National AIDS Council for scientific testing.
The Ministry's director of clinical services, James Simpungwe, told a parliamentary committee on health last week that Tetrasil - whose main component is silver - is used as a medical disinfectant and to sterilise swimming pools.
The director of the HIV treatment advocacy and literacy campaign, Felix Mwanza, told the committee that the drug is being administered to patients at cost of US$ 1,500 per injection. He said so far 26 people have received a course of treatment of the drug.
There are an increasing number of reports in Zambia that people with HIV/AIDS are being administered drugs that have not been subjected to scientific tests.
The Health Ministry's permanent secretary, Simon Miti, told the 'Zambia Daily Mail' last week that people claiming to cure HIV/AIDS were taking advantage of unclear guidelines in Zambia's pharmaceuticals act to test their concoctions on unsuspecting and desperate individuals.
Mr Miti said if the situation continues, the police, immigration and the drug enforcement commission would address the situation.
Approximately 1.1 million Zambians are infected with HIV, including 130,000 children, according to estimates by the World Health Organisation (WHO).
070607
AO070602
Copyright © 2007 - afrol News. All rights reserved. Reproducing or buying afrol News' articles.
AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .